Targeting the gut microbiome may offer a strategic approach to enhance immune reconstitution following ART. In clinical trial, Bifidobacterium and DHA-lipid may serve as novel therapeutic strategies to modulate inflammation and improve immune function in PLWH (NCT02640625, NCT02164344, and NCT02005900)....